Clinical Trials
4
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:4
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 2
4 (100.0%)A Study to Evaluate the Efficacy and Safety of CIN-102 (deudomperidone) in Adult Subjects with Idiopathic Gastroparesis.
Phase 2
Not yet recruiting
- Conditions
- Idiopathic Gastroparesis
- Interventions
- Drug: CIN-102 Dose 15mgDrug: CIN-102 Dose 10mgDrug: Placebo
- First Posted Date
- 2025-03-27
- Last Posted Date
- 2025-03-27
- Lead Sponsor
- CinDome Pharma, Inc.
- Target Recruit Count
- 400
- Registration Number
- NCT06899217
A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adults With Diabetic Gastroparesis
Phase 2
Recruiting
- Conditions
- Diabetic Gastroparesis
- Interventions
- Drug: CIN-102 Dose 15mg or 10mgDrug: Placebo
- First Posted Date
- 2023-04-27
- Last Posted Date
- 2025-06-10
- Lead Sponsor
- CinDome Pharma, Inc.
- Target Recruit Count
- 360
- Registration Number
- NCT05832151
- Locations
- 🇺🇸
Digestive Health Specialists of the Southeast, Dothan, Alabama, United States
🇺🇸G & L Research, LLC, Foley, Alabama, United States
🇺🇸Clinical Research Associates, LLC, Huntsville, Alabama, United States
A Scintigraphy Study in Adults With Diabetic Gastroparesis
Phase 2
Terminated
- Conditions
- Diabetic Gastroparesis
- Interventions
- Drug: Placebo for CIN-102Drug: CIN-102 Dose 1Drug: CIN-102 Dose 2
- First Posted Date
- 2019-12-23
- Last Posted Date
- 2021-08-10
- Lead Sponsor
- CinDome Pharma, Inc.
- Target Recruit Count
- 2
- Registration Number
- NCT04208698
- Locations
- 🇺🇸
Research Site, El Paso, Texas, United States
A Phase 2 Study of CIN-102 in Adults With Idiopathic and Diabetic Gastroparesis
Phase 2
Completed
- Conditions
- Gastroparesis
- Interventions
- Drug: CIN-102 Dose 1Drug: PlaceboDrug: CIN-102 Dose 2Drug: CIN-102 Dose 3
- First Posted Date
- 2019-07-19
- Last Posted Date
- 2021-07-21
- Lead Sponsor
- CinDome Pharma, Inc.
- Target Recruit Count
- 73
- Registration Number
- NCT04026997
- Locations
- 🇺🇸
Research Site 101, Chula Vista, California, United States
🇺🇸Research Site 114, Jacksonville, Florida, United States
🇺🇸Research Site 117, Miami, Florida, United States
News
No news found